Roquinimex
Roquinimex (FCF 89, Linomide, LS 2616) is a novel immunomodulator augmenting natural killer (NK) cell activity and T-lymphocyte related effector functions. Roquinimex is a potent oral active tumor antiangiogenic agent. Roquinimex inhibits the secretion of TNF-α.
| Trivial name | FCF 89, Linomide, LS 2616 |
| Catalog Number | S2307 |
| Molecular Formula | C29H31F3N6O3 |
| CAS# | 84088-42-6 |
| Inchi | InChI=1S/C29H31F3N6O3/c1-37-10-12-38(13-11-37)17-21-6-7-22(15-24(21)29(30,31)32)35-26(39)14-19-2-8-23(9-3-19)41-27-16-25(33-18-34-27)36-28(40)20-4-5-20/h2-3,6-9,15-16,18,20H,4-5,10-14,17H2,1H3,(H,35,3 9)(H,33,34,36,40) |
| Inchi Key | FTODTDQFHDJWIQ-UHFFFAOYSA-N |
| SMILES | CN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)CC3=CC=C(C=C3)OC4=NC=NC(=C4)NC(=O)C5CC5)C(F)(F)F |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/roquinimex.html |
| Additional Information | https://file.selleck.cn/downloads/struct/roquinimex-chemical-structure-s2307.gif |